SINGAPORE, May 16, 2025 /PRNewswire/ — In a bold step toward equitable cancer care, Gene Solutions introduces SPOT-MAS Lung, a next-generation blood-based test powered by artificial intelligence (AI) and multi-omics analysis. Designed with lung-specific features, SPOT-MAS Lung may offer a promising approach for earlier detection in Asia—especially among asymptomatic individuals who are often missed by

We are delighted to announce an important milestone: Medical Genetics JSC, a subsidiary of Gene Solutions group, has become an accredited Next Generation Sequencing (NGS) laboratory in Vietnam by the prestigious College of American Pathologists (CAP). This accreditation signifies our compliance with the highest standards in laboratory testing, particularly in the category of high complexity

As a significant development for the MCED community, Dr. Le Son Tran, the lead R&D scientist from Medical Genetics Institute Ho Chi Minh City and Gene Solutions is set to present breakthrough findings at the upcoming prestigious oncology conference this weekend. The landscape of MCED tests based on detecting methylation changes in cfDNA has evolved

Gene Solutions, a pioneering brand in the field of medical genetics from Vietnam, has won two Merit Awards at the ESMO ASIA 2023 event. The company has been successful in applying Next-Generation Sequencing (NGS) technology in Vietnam and aims to expand globally with its unique advantages in technology application. Gene Solutions’ participation in ESMO ASIA

Thursday, August 3, 2023. Yokohama, Japan. The press conference on 03 August highlighted the first day of 2023 ASCO Breakthrough meeting in Yokohama. The American Society of Clinical Oncologoy (ASCO) meetings serve as leading education events for sharing knowledge and Asco Breakthrough is the premier scientific and educational event outside the United States. Dr. Julie

  Thursday, August 3 at 12:00-13:00 JST Location: Pacifico Yokohama. The American Society of Clinical Oncology is a leading, global society of more than 45,000 oncology professionals in over 150 countries. This year ASCO Breakthrough Meeting in Yokohama, Japan brings the world’s top oncology professionals to reveal how utting-edge advances in cancer care technology and